TG Thera posts early-stage data for Briumvi in myasthenia gravis; launches mid-stage trial

EPD prepares for Q3 earnings: Cash flow, growth capex, and yield in focus

Bullish on Anthropic but don’t want to wait until the IPO? Here’s how you can invest today.

Axogen forecasts at least $290M 2026 revenue, adds $7M from BioCircuit while planning prostate market development in 2027

Midday Pulse: S&P 500 top intraday losers